封面
市场调查报告书
商品编码
1741366

肺癌手术市场:按产品类型、按手术类型、按程序、按癌症分期、按最终用户、按地区

Lung Cancer Surgery Market, By Product Type, By Surgery Type, By Procedure, By Cancer Stage, By End user, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年肺癌手术市场规模估计为 66.1 亿美元,预计到 2032 年将达到 90 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 4.5%。

分析范围 分析详细信息
基准年 2024 市场规模(2025年) 66.1亿美元
效能数据 2020-2024 预测期 2025-2032
预测期内的复合年增长率(2025-2032) 4.50% 预计金额(2032年) 90亿美元

肺癌是一种起源于肺部的癌症。肺部是位于胸腔内的两个类似海绵的器官,在人体吸气时吸收氧气,呼气时会释放二氧化碳。肺癌是全球最常见的癌症之一,也是癌症死亡的主要原因。

肺癌手术是一种切除肿瘤或受癌症影响的肺部区域的医疗程序。手术类型取决于肿瘤在肺部的大小和位置、肺癌的类型(非小细胞切除术或小细胞肺癌)以及患者的整体状况。肺癌手术有几种类型,包括肺叶切除术和切除术。肺癌手术是治疗这种恶性疾病的关键方法。手术切除病变的肺组织使医务人员能够针对局部肿瘤,提供有效的治疗和治癒的可能性。此手术的成功取决于早期发现、准确的分期和患者的整体状况。从传统的开放性手术到VATS(电视辅助胸腔手术)等微创技术,肺癌手术不断发展,旨在最大限度地减少创伤并促进復原。肺癌手术仍然是多学科对抗肺癌的重要组成部分。

市场动态:

预计肺癌盛行率的上升将在预测期内推动全球肺癌手术市场的成长。例如,根据世界癌症研究基金会国际组织2022年3月发布的数据,2020年全球整体将新增超过220万例肺癌新患者。

本报告的主要特点

  • 本报告对全球肺癌手术市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和复合年增长率。
  • 它还强调了每个细分市场的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球肺癌手术市场的主要企业是根据公司概况、产品系列、主要亮点、财务绩效和策略等参数列出的。
  • 透过本报告的见解,负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 「全球肺癌手术市场」报告涉及该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球肺癌手术市场的各种策略矩阵来促进他们的决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
      • 肺癌发生率上升
    • 限制因素
      • 肺癌手术费用高昂
    • 机会
      • 采用微创技术
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球肺癌手术市场:COVID-19感染疾病的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

第五章全球肺癌手术市场依产品类型(2020-2032)

  • 手术器械
  • 监控与视觉化系统
  • 内视镜手术设备
  • 机器人辅助胸腔外科手术系统
  • 其他的

6. 全球肺癌手术市场依手术类型(2020-2032)

  • 开放性手术
  • 微创手术

7. 全球肺癌手术市场(依程序划分)(2020-2032)

  • 切除术
  • 切除术/楔形切除术
  • 肺切除术
  • 袖状切除术
  • 扩大切除术

8. 全球肺癌手术市场(依癌症分期划分)(2020-2032 年)

  • 早期
  • 后期

9. 全球肺癌手术市场(依最终用户划分)(2020-2032 年)

  • 医院
  • 门诊手术中心
  • 专科诊所

第 10 章 按地区分類的全球肺癌手术市场(2020-2032 年)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十一章竞争格局

  • Ethicon(Johnson & Johnson)
  • Medtronic
  • Intuitive Surgical
  • Olympus Corporation
  • Karl Storz
  • Accuray Incorporated
  • AngioDynamics
  • Varian Medical Systems
  • Siemens Healthineers
  • Atricure, Inc.
  • Novadaq Technologies Inc.
  • GE Healthcare
  • Scanlan International Inc

第十二章 章节

  • 分析方法
  • 关于出版商
简介目录
Product Code: CMI6146

Lung Cancer Surgery Market is estimated to be valued at USD 6.61 Bn in 2025 and is expected to reach USD 9.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.61 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.50% 2032 Value Projection: USD 9.00 Bn

Lung cancer is a type of cancer that begins in the lungs, which are two spongy organs in chest that take in oxygen when a person inhale and release carbon dioxide when a person exhale. It is one of the most common cancers in the world and is a leading cause of cancer deaths.

Lung cancer surgery is a medical procedure performed to remove a tumor or a portion of the lung affected by cancer. The type of surgery depends on the size and location of the tumor in the lung, the type of lung cancer (non-small cell or small cell lung cancer), and the patient's overall health. There are several types of lung cancer surgeries such as lobectomy, segmentectomy, etc. Lung cancer surgery stands as a pivotal approach to treating this aggressive disease. By surgically removing affected lung tissue, medical professionals can target localized tumors, offering a chance for effective treatment and the potential cure. The procedure's success relies on early detection, accurate staging, and the patient's overall health. From traditional open surgeries to minimally invasive techniques like VATS (Video-Assisted Thoracoscopic Surgery), lung cancer surgery has evolved to minimize trauma and enhance recovery. It remains a crucial component in the multidisciplinary battle against lung cancer.

Market Dynamics:

The increasing prevalence of lung cancer is expected to drive the growth of the global lung cancer surgery market over the forecast period. For instance, according to data published in March 2022 by the World Cancer Research Fund International, globally, there were more than 2.2 million new cases of lung cancer in 2020.

Key features of the study:

  • This report provides in-depth analysis of the global lung cancer surgery market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lung cancer surgery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, Olympus Corporation, Karl Storz, Accuray Incorporated, AngioDynamics, Varian Medical Systems, Siemens Healthineers, Atricure, Inc., Novadaq Technologies Inc., GE Healthcare and Scanlan International Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lung cancer surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer surgery market

Lung cancer surgery market Detailed Segmentation:

  • By Product Type:
    • Surgical Instruments
    • Monitoring & Visualizing System
    • Endosurgical Equipment
    • Robotic-Assisted Thoracic Surgery Systems
    • Others
  • By Surgery Type:
    • Open Surgery
    • Minimally Invasive Surgery
  • By Procedure:
    • Lobectomy
    • Segmentectomy/Wedge Resection
    • Pneumonectomy
    • Sleeve Resection
    • Extended Resection
  • By Cancer Stage:
    • Early-Stage
    • Advanced-Stage
  • By End user:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Ethicon (Johnson & Johnson)
    • Medtronic
    • Intuitive Surgical
    • Olympus Corporation
    • Karl Storz
    • Accuray Incorporated
    • AngioDynamics
    • Varian Medical Systems
    • Siemens Healthineers
    • Atricure, Inc.
    • Novadaq Technologies Inc.
    • GE Healthcare
    • Scanlan International Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Lung Cancer Surgery, By Surgery Type
    • Market Lung Cancer Surgery, By Product Type
    • Market Lung Cancer Surgery, By Procedure
    • Market Lung Cancer Surgery, By Cancer Stage
    • Market Lung Cancer Surgery, By End User
    • Market Lung Cancer Surgery , By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of lung cancer
    • Restraints
  • High Cost of Lung Cancer Surgery
    • Opportunities
  • Adoption of Minimally Invasive Techniques
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Lung Cancer Surgery Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Lung Cancer Surgery Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Monitoring & Visualizing System
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Endosurgical Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Robotic-Assisted Thoracic Surgery Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Lung Cancer Surgery Market, By Surgery Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Open Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Minimally Invasive Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Lung Cancer Surgery Market, By Procedure, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lobectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Segmentectomy/Wedge Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Pneumonectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Sleeve Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Extended Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

8. Global Lung Cancer Surgery Market, By Cancer Stage, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Early-Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Advanced-Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Lung Cancer Surgery Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

10. Global Lung Cancer Surgery Market, By Geography, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Intuitive Surgical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Karl Storz
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Accuray Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AngioDynamics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Varian Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Atricure, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novadaq Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Scanlan International Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us